Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0FH5N
|
||||
Former ID |
DIB014185
|
||||
Drug Name |
IW-6118
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Phase 2 | [523013] | ||
Company |
Ironwood Pharmaceuticals Inc
|
||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Modulator | [544183] | |
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.